11 participants
Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fumarate (Tecfidera) or Diroximel Fumarate (Vumerity)
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-08-11
- Start Date:
- 2023-03-07
- Completion:
- 2026-09-01
Conditions
- Multiple Sclerosis (MS) Relapsing Remitting
Interventions
- DRUG
No Results Yet